For individuals with a history of disordered eating, discuss the appropriate intensity of food tracking with your healthcare provider
This helps to prevent overeating, which is why these medications are effective for both weight loss and maintaining healthy blood glucose levels
Promising avenues include targeting tau pathology, neuroinflammation, mitochondrial dysfunction, brain insulin resistance, vascular integrity, and infectious triggers
It is also worth noting that rapid weight loss associated with GLP-1 receptor agonist therapy is linked to an increased risk of gallstone formation and gallbladder disease (cholecystitis), a class effect recognised in the SmPCs for semaglutide and tirzepatide
[14] OSA Pathway Continues Sleep apnea indication coverage continues with same strict criteria (AHI 30, failed semaglutide trial)
However, this is anecdotal and not validated by clinical research